Geranylgeranylacetone inhibits ovarian cancer progression in vitro and in vivo.
Hashimoto K, Morishige K, Sawada K, Ogata S, Tahara M, Shimizu S, Sakata M, Tasaka K, Kimura T.
Hashimoto K, et al. Among authors: sawada k.
Biochem Biophys Res Commun. 2007 Apr 27;356(1):72-7. doi: 10.1016/j.bbrc.2007.02.102. Epub 2007 Feb 28.
Biochem Biophys Res Commun. 2007.
PMID: 17343825
In our previous study, GGA was shown to inhibit ovarian cancer invasion by attenuating Rho activation [K. Hashimoto, K. Morishige, K. Sawada, M. Tahara, S. Shimizu, M. Sakata, K. Tasaka, Y. ...
In our previous study, GGA was shown to inhibit ovarian cancer invasion by attenuating Rho activation [K. Hashimoto, K. Morish …